Abstract:Background . Although multiple types of cancers demonstrated favorable outcome after immunotherapy of PD-1/PD-L1 blockade, the specific regulatory mechanism of PD genes in gastric cancer (GC) remains largely unknown. Materials and Methods . Expression of RNA, copy number variants, and clinical parameters of GC individuals from TCGA were analyzed. Coexpressed genes for PD-1, PD-L1, and PD-L2 were selected by correlation analysis and confirmed by STRING. Gene Ontology and KEGG pathway analyses were performed by clusterProfiler. The influence of PD-1/PD-L1/PD-L2 on immune cell infiltration was investigated by MCP-counter. Results . PD-L2 demonstrated significant relation with clinical stage of GC ( P = 0.043 ). Survival analysis showed that PD-1 expression was correlated with better prognosis of GC patients ( HR = 0.70 , P = 0.031 ), but PD-L2 expression was related with worse survival ( HR = 1.42 , P = 0.032 ). Mutation of PIK3CA could alter the level of PD-1, PD-L1, and PD-L2 ( P < 0.001 ), and TP53 mutation demonstrated significant correlation with PD-L1 ( P = 0.015 ) and PD-L2 ( P = 0.014 ) expression. Enrichment analysis of PD-1/PD-L1/PD-L2 coexpressed genes indicated a biological process of mononuclear cell proliferation, leukocyte cell-cell adhesion, and lymphocyte activation as well as KEGG pathways including cell differentiation of Th1 and Th2, cell differentiation of Th17, and hematopoietic cell landscape. As for immune infiltration analysis, PD-1 was mainly related with cytotoxic lymphocytes and endothelial cells; PD-L1 were associated with monocytic lineage; PD-L2 showed significant correlation with myeloid dendritic cells. Conclusion . PD-1 expression showed association with better prognosis of GC, and PD-L2 expression was related with worse survival. Mutations of PIK3CA and TP53 significantly correlated with PD-1/PD-L1/PD-L2 axis. PD-1/PD-L1/PD-L2 coexpressed genes demonstrated enrichment in mononuclear cell proliferation, leukocyte cell-cell adhesion, and lymphocyte activation as well as KEGG pathways including cell differentiation of Th1, Th2, and Th17.

Analysis of the P42.3 Protein Structure and Regulatory Network

P42.3 Gene Expression in Gastric Cancer Cell and Its Protein Regulatory Network Analysis

Identification and Characterization of a Novel P42.3 Gene As Tumor-Specific and Mitosis Phase-Dependent Expression in Gastric Cancer

Expression of Ngf Family and Their Receptors in Gastric Carcinoma: A Cdna Microarray Study

p42.3: A promising biomarker for the progression and prognosis of human colorectal cancer

MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer.

Identification Oftyrobpandc1qbas Two Novel Key Genes with Prognostic Value in Gastric Cancer by Network Analysis

Positive Relationship Between P42.3 Gene and Inflammation in Chronic Non-Atrophic Gastritis.

Differential Expression of P42.3 in Low- and High-Grade Gliomas

Overexpression of P42.3 Promotes Cell Growth and Tumorigenicity in Hepatocellular Carcinoma

Depletion of P42.3 Gene Inhibits Proliferation and Invasion in Melanoma Cells

Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library

Cell Cycle-Dependent Expression of P42.3 Promotes Mitotic Progression in Malignant Transformed Cells.

High Expression of Pituitary Tumor Gene Family is a Predictor for Poor Prognosis of Gastric Cancer

Comprehensive bioinformatics and experimental analysis of SH3PXD2B reveals its carcinogenic effect in gastric carcinoma

Pangenomic analysis of Chinese gastric cancer

Bioinformatics Analysis of Key Genes and circRNA-miRNA-mRNA Regulatory Network in Gastric Cancer

Integrated analysis to identify biological features and molecular markers of poorly cohesive gastric carcinoma (PCC)

SQSTM1/p62 promotes the progression of gastric cancer through epithelial-mesenchymal transition

Circ_0000190 suppresses gastric cancer progression potentially via inhibiting miR-1252/PAK3 pathway

Profiles of PD-1, PD-L1, PD-L2 in Gastric Cancer and Their Relation with Mutation, Immune Infiltration, and Survival